KUALA LUMPUR: Bursa Malaysia slowed its ascent on Wednesday amid a negative report over the success of the early-stage trial of a coronavirus vaccine.
The FBM KLCI managed to eke out a slight 1.42-point gain to 1,425.39 to extend its rally for a sixth straight day although there were signs momentum was slowing.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
